Literature DB >> 12491327

Proof of principle in the selective treatment of cancer by antibody-directed enzyme prodrug therapy: the development of a highly potent prodrug.

Lutz F Tietze1, Tim Feuerstein, Anja Fecher, Frank Haunert, Olaf Panknin, Ulrich Borchers, Ingrid Schuberth, Frauke Alves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12491327     DOI： 10.1002/1521-3773(20020301)41:5<759::aid-anie759>3.0.co;2-7

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  3 in total

1.  A unique class of duocarmycin and CC-1065 analogues subject to reductive activation.

Authors:  Wei Jin; John D Trzupek; Thomas J Rayl; Melinda A Broward; George A Vielhauer; Scott J Weir; Inkyu Hwang; Dale L Boger
Journal:  J Am Chem Soc       Date:  2007-11-17       Impact factor: 15.419

2.  Determination of the biological activity and structure activity relationships of drugs based on the highly cytotoxic duocarmycins and CC-1065.

Authors:  Lutz F Tietze; Birgit Krewer; J Marian von Hof; Holm Frauendorf; Ingrid Schuberth
Journal:  Toxins (Basel)       Date:  2009-12-02       Impact factor: 4.546

3.  Mutagenic activity of quaternary ammonium salt derivatives of carbohydrates.

Authors:  Barbara Dmochowska; Karol Sikora; Anna Woziwodzka; Jacek Piosik; Beata Podgórska
Journal:  Beilstein J Org Chem       Date:  2016-07-12       Impact factor: 2.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.